Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS
· Delayed Price · Currency is USD
0.590
+0.100 (20.41%)
Mar 6, 2026, 4:00 PM EST
Pharma-Bio Serv Ratios and Metrics
Market cap in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | 2020 - 2016 |
| Market Capitalization | 11 | 12 | 13 | 20 | 20 | 24 | Upgrade
|
| Market Cap Growth | -41.89% | -7.06% | -31.76% | -1.11% | -16.81% | -20.06% | Upgrade
|
| Enterprise Value | 0 | 2 | 1 | 5 | 6 | 8 | Upgrade
|
| Last Close Price | 0.49 | 0.47 | 0.44 | 0.60 | 0.57 | 0.58 | Upgrade
|
| PE Ratio | - | - | - | 14.89 | 19.60 | - | Upgrade
|
| Forward PE | 4.45 | 208.00 | 208.00 | 208.00 | 208.00 | 208.00 | Upgrade
|
| PS Ratio | 1.25 | 1.38 | 1.40 | 1.15 | 1.02 | 1.18 | Upgrade
|
| PB Ratio | 0.94 | 1.04 | 0.97 | 1.21 | 1.19 | 1.25 | Upgrade
|
| P/TBV Ratio | 0.94 | 1.04 | 0.97 | 1.21 | 1.19 | 1.25 | Upgrade
|
| P/FCF Ratio | - | - | - | 10.36 | 34.42 | 29.87 | Upgrade
|
| P/OCF Ratio | - | - | - | 10.32 | 33.31 | 29.47 | Upgrade
|
| PEG Ratio | - | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 | Upgrade
|
| EV/Sales Ratio | 0.04 | 0.19 | 0.07 | 0.31 | 0.31 | 0.39 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 4.56 | 4.91 | - | Upgrade
|
| EV/EBIT Ratio | - | - | - | 4.75 | 5.12 | - | Upgrade
|
| EV/FCF Ratio | -1.79 | - | - | 2.82 | 10.49 | 9.97 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 0.26 | 0.35 | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.18 | 0.85 | 0.78 | Upgrade
|
| Net Debt / Equity Ratio | -0.91 | -0.91 | -0.91 | -0.91 | -0.84 | -0.89 | Upgrade
|
| Net Debt / EBITDA Ratio | 18.74 | 18.74 | 9.93 | -12.55 | -11.40 | 4.46 | Upgrade
|
| Net Debt / FCF Ratio | 48.87 | 48.87 | 17.28 | -7.77 | -24.38 | -21.22 | Upgrade
|
| Asset Turnover | 0.60 | 0.60 | 0.53 | 0.84 | 0.87 | 0.75 | Upgrade
|
| Quick Ratio | 7.60 | 7.60 | 8.08 | 8.78 | 9.23 | 8.27 | Upgrade
|
| Current Ratio | 7.70 | 7.70 | 8.32 | 9.01 | 9.46 | 8.55 | Upgrade
|
| Return on Equity (ROE) | -0.78% | -0.78% | -5.21% | 8.02% | 5.68% | -10.04% | Upgrade
|
| Return on Assets (ROA) | -2.66% | -2.66% | -4.45% | 3.44% | 3.29% | -8.95% | Upgrade
|
| Return on Invested Capital (ROIC) | -54.01% | -56.62% | -96.81% | 42.55% | 42.85% | -74.35% | Upgrade
|
| Return on Capital Employed (ROCE) | -5.40% | -5.40% | -8.90% | 6.30% | 6.30% | -18.10% | Upgrade
|
| Earnings Yield | -0.90% | -0.81% | -5.84% | 6.71% | 5.10% | -8.81% | Upgrade
|
| FCF Yield | -1.97% | -1.79% | -5.46% | 9.65% | 2.90% | 3.35% | Upgrade
|
| Payout Ratio | - | - | - | 131.57% | 342.37% | - | Upgrade
|
| Buyback Yield / Dilution | 0.07% | 0.07% | 0.10% | 0.15% | 0.56% | -0.53% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.